Connor, Clark & Lunn Investment Management (CC&L)’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-33,367
| Closed | -$295K | – | 1466 |
|
|
2022
Q3 | $295K | Hold |
33,367
| – | – | ﹤0.01% | 927 |
|
|
2022
Q2 | $257K | Hold |
33,367
| – | – | ﹤0.01% | 896 |
|
|
2022
Q1 | $315K | Sell |
33,367
-60
| -0.2% | -$566 | ﹤0.01% | 863 |
|
|
2021
Q4 | $232K | Hold |
33,427
| – | – | ﹤0.01% | 947 |
|
|
2021
Q3 | $318K | Buy |
33,427
+1,489
| +5% | +$14.2K | ﹤0.01% | 861 |
|
|
2021
Q2 | $317K | Sell |
31,938
-1,355
| -4% | -$13.4K | ﹤0.01% | 856 |
|
|
2021
Q1 | $390K | Buy |
33,293
+2,042
| +7% | +$23.9K | ﹤0.01% | 822 |
|
|
2020
Q4 | $1.12M | Sell |
31,251
-727
| -2% | -$26K | 0.01% | 613 |
|
|
2020
Q3 | $442K | Sell |
31,978
-4,553
| -12% | -$62.9K | ﹤0.01% | 742 |
|
|
2020
Q2 | $602K | Sell |
36,531
-499
| -1% | -$8.22K | ﹤0.01% | 717 |
|
|
2020
Q1 | $315K | Sell |
37,030
-4,559
| -11% | -$38.8K | ﹤0.01% | 791 |
|
|
2019
Q4 | $947K | Sell |
41,589
-3,133
| -7% | -$71.3K | 0.01% | 555 |
|
|
2019
Q3 | $640K | Sell |
44,722
-20,065
| -31% | -$287K | ﹤0.01% | 623 |
|
|
2019
Q2 | $863K | Sell |
64,787
-5,002
| -7% | -$66.6K | 0.01% | 604 |
|
|
2019
Q1 | $1.21M | Sell |
69,789
-611
| -0.9% | -$10.6K | 0.01% | 493 |
|
|
2018
Q4 | $963K | Sell |
70,400
-3,409
| -5% | -$46.6K | 0.01% | 562 |
|
|
2018
Q3 | $1.59M | Sell |
73,809
-1,067
| -1% | -$23K | 0.01% | 481 |
|
|
2018
Q2 | $3.21M | Buy |
74,876
+12,739
| +21% | +$546K | 0.02% | 385 |
|
|
2018
Q1 | $4.05M | Buy |
62,137
+11,897
| +24% | +$776K | 0.02% | 313 |
|
|
2017
Q4 | $3.67M | Buy |
50,240
+4,108
| +9% | +$300K | 0.02% | 330 |
|
|
2017
Q3 | $4.23M | Buy |
46,132
+32,856
| +247% | +$3.01M | 0.03% | 321 |
|
|
2017
Q2 | $878K | Buy |
13,276
+10,212
| +333% | +$675K | 0.01% | 520 |
|
|
2017
Q1 | $665K | Sell |
3,064
-1,447
| -32% | -$314K | ﹤0.01% | 575 |
|
|
2016
Q4 | $417K | Sell |
4,511
-456
| -9% | -$42.2K | ﹤0.01% | 638 |
|
|
2016
Q3 | $671K | Buy |
4,967
+1,811
| +57% | +$245K | ﹤0.01% | 531 |
|
|
2016
Q2 | $320K | Buy |
+3,156
| New | +$320K | ﹤0.01% | 663 |
|